LECTRUM 7.5MG INJECTION

LECTRUM 7.5MG INJECTION contains Leuprorelin Acetate as its active ingredient. Leuprorelin Acetate is a synthetic hormone analog of gonadotropin-releasing hormone (GnRH). It is primarily used in the treatment of hormone-dependent conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty.

Uses:

LECTRUM 7.5MG INJECTION is prescribed for various medical conditions where hormonal regulation is required. It is commonly used in the management of advanced prostate cancer by reducing testosterone levels, which can slow the growth of cancer cells. Additionally, it is used to treat endometriosis by suppressing ovarian function and reducing estrogen levels. In children with precocious puberty, Leuprorelin Acetate helps delay early puberty onset. It may also be used in the treatment of uterine fibroids to reduce symptoms associated with excessive bleeding and pelvic pain.

Administration:

LECTRUM 7.5MG INJECTION is administered via intramuscular injection by healthcare professionals. The dosage and frequency of administration vary depending on the patient’s condition and medical history. Treatment duration may range from several weeks to months, and periodic monitoring is essential to assess treatment response and adjust dosage if necessary.

Side Effects:

Common side effects of LECTRUM 7.5MG INJECTION may include hot flashes, sweating, fatigue, decreased libido, erectile dysfunction (in men), vaginal dryness (in women), mood swings, and injection site reactions such as pain or irritation. In some cases, it may cause more serious side effects such as bone thinning (osteoporosis), mood changes, or allergic reactions. Patients should promptly report any unusual or concerning symptoms to their healthcare provider.

Precautions:

Before using LECTRUM 7.5MG INJECTION, inform your healthcare provider about any pre-existing medical conditions, allergies, or medications you are currently taking. Special precautions may be necessary for individuals with a history of bone disorders, cardiovascular disease, or those who are pregnant or breastfeeding. Close monitoring for adverse reactions during treatment is essential.

Contraindications:

LECTRUM 7.5MG INJECTION should not be used in patients with known hypersensitivity to Leuprorelin Acetate or any of the components of the formulation. It should also be avoided in pregnant or breastfeeding women, as well as in individuals with severe bone disorders or untreated hormone-dependent cancers such as breast or prostate cancer.

Conclusion:

LECTRUM 7.5MG INJECTION, containing Leuprorelin Acetate, is an important medication for the management of hormone-dependent conditions such as prostate cancer, endometriosis, uterine fibroids, and precocious puberty. While generally well-tolerated, patients should be aware of potential side effects and follow their healthcare provider’s instructions for safe and effective use.